Stocks: Catching the Market Blues

Gopal,Kevin;

Stocks: Catching the Market Blues

June 1, 2001

By Kevin Gopal

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-06-01-2001

Volume 0

Issue 0

Buckinghamshire, UK-The pharma industry may be countercyclical, but it’s not immune to market trends. Nycomed Amersham recently postponed a partial US stock flotation of its life sciences company, ABBiotech, because of market weakness.

Articles in this issue

Industry Under Investigation

Covering the Bases

Emotion - The New Brand Integrator

For Love of the Game

Field of Dreams

Workshop: Access Options

Emotion - The New Brand Integrator

Rx-to-OTC: Unwanted Attention

Emotion - Biotech Renaissance Man

Biotech Renaissance Man

Relocation: Coming to America

Biotechnology: German Industry Beefs Up

Stocks: Catching the Market Blues

Gathering Light

Related Content

Statistically and Clinically Significant Paths to Value Proposition

Ira Studin, PhD

February 12th 2025

Article

Demonstrating clinical benefit is the ultimate gateway to smoother patient access.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs

February 10th 2025

Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Abcuro Secures $200 Million in Series C Funding to Advance Ulviprubart for Inclusion Body Myositis

Don Tracy, Associate Editor

February 12th 2025

Article

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations

Miranda Schmalfuhs

January 30th 2025

Podcast

Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.